NOVELION THERAPEUTICS INC. 4
4 · NOVELION THERAPEUTICS INC. · Filed May 11, 2017
Insider Transaction Report
Form 4
Buono Linda
See Remarks
Transactions
- Exercise/Conversion
Common Shares
2017-05-09+274→ 274 total - Exercise/Conversion
Restricted Stock Units
2017-05-09−274→ 546 total→ Common Shares (274 underlying) - Tax Payment
Common Shares
2017-05-09$9.42/sh−93$876→ 181 total
Footnotes (4)
- [F1]Reflects a one-for-five share consolidation of the common shares of the Issuer effective December 16, 2016.
- [F2]Each restricted stock unit represents a contingent right to receive one common share.
- [F3]The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person.
- [F4]33.34% of the grant vested on May 9, 2017. Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer or one of its affiliates, 33.33% of the grant will vest on May 9, 2018 and 33.33% of the grant will vest on May 9, 2019.